Skip to content

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

News

Choose Year
Search Press Releases

Found 172 Results

September 16, 2021

Sernova Signs Collaboration Agreement to Advance Conformal Coated Immune Protected Therapeutic Cells for Diabetes with the University of Miami

August 9, 2021

Sernova to Present Corporate Update at Canaccord Genuity’s 41st Annual Growth Conference

July 5, 2021

Sernova Announces 2021 Annual Meeting Results: Shareholders Approve Resolutions with Overwhelming Majority

June 30, 2021

Industry Veteran Frank Shannon Joins Sernova as VP Clinical Development and Regulatory Affairs

June 27, 2021

Sernova’s Principal Investigator Presents Interim Data and Positive Patient Outcomes of Phase I/II T1D Study at the American Diabetes Association 81st Scientific Sessions

June 7, 2021

Sernova’s Principal Investigator Presents Positive New Data from Ongoing Type 1 Diabetes (T1D) Clinical Trial at ATC 2021 Virtual Connect Conference

June 1, 2021

Sernova Announces American Transplant Congress 2021Virtual Connect Abstract Presentation

May 17, 2021

Sernova to Present at Global Partnership Family Office – HealthCare & Biotechnology TSX Showcase

May 4, 2021

Sernova Announces the Nomination of Seasoned Pharma Executive Dr. Mohammad Azab to its Board of Directors

April 28, 2021

Sernova KOL Event Highlights Novel Cell Therapy Approach for the Potential Treatment of Thyroid Disease

«...8 91011 12...»

IR Contact

David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

700 Collip Circle
Suite 114,
London, ON, Canada N6G 4X8
info@sernova.com

Company

About Us
Leadership
Board of Directors
Careers
Contact

Science

Our Focus
Type 1 diabetes
Pipeline
Library

Investors

Overview
News
Events
Financial Reports
Stock Information
Corporate Governance

Privacy Policy
Legal Notice

© 2025 Sernova Biotherapeutics. All rights reserved.

Scroll to Top